Brind.

Wells Fargo initiated coverage with a Buy rating for Revolution Medicines on August 29, 2025.

1 report, 1 independent Updated Aug 29

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Revolution Medicines (United States)Wells Fargo

Keep exploring

The entities involved

Revolution Medicines (United States)
company in Redwood City, United States

Nothing else this week.
Wells Fargo
American multinational banking and financial services company
- Wells Fargo upgraded Sweetgreen stock to overweight from equal weight on September 28, 2026.Mon 16:33
- Capital Research Global Investors acquired and increased its stake in Wells Fargo stock on June 19, 2026.Mon 16:28

Coverage

Newest first; wire copies grouped

Aug 29Insider MonkeyHere’s What the Wall Street Thinks About Revolution Medicines (RVMD) Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the Best Mid Cap Growth Stocks to Buy According to Hedge Funds. On August 6, Re